Diabetic Medicine · 1991 · 13 citations · 23 references
MedicineEndocrinologyPathologyAutoimmunityDiabetologyImmunogeneticsAutoantibodiesDiabetes MellitusPancreatic DiseasesPancreatic DisordersPancreatic EndocrinologyPancreatic HormonesCystic Fibrosis-related DiabetesImpaired Glucose ToleranceIslet AutoimmunityPancreatic Islet CellsType 1 Diabetes AssociationsType 1 Diabetes Pathophysiology
Islet cell cytoplasmic antibodies were determined in 85 individuals 60 to 74 years old with fasting hyperglycaemia, in 65 patients with cystic fibrosis, in 113 patients with pancreatitis, in 21 patients with Turner's phenotype, and in 135 first-degree relatives of patients with Type 1 (insulin-dependent) diabetes. Islet cell antibodies were absent in all 60 to 74-year-old subjects with fasting hyperglycaemia detected by screening, and who did not require insulin treatment within 3 years. Islet cell antibodies were also absent in all patients with pancreatitis, cystic fibrosis, or Turner's phenotype. Islet cell antibodies were detected in 2 out of 135 (1.5%) first-degree relatives of new Type 1 diabetic patients, and in 1 out of 371 (0.3%) non-diabetic control subjects. During 12 years of follow-up 1 of the 2 first-degree relatives with islet cell antibodies and the only positive control developed Type 1 diabetes. It is suggested that islet cell antibodies are primarily associated with Type 1 diabetes and not with other disorders of glucose tolerance.
23
Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes
Ezio Bonifacio, Marion Shattock, B.M. Dean et al. · The Lancet · 1990 · 351 citations
Norbert Freinkel, Boyd E. Metzger, Richard Phelps et al. · Diabetes · 1985 · 214 citations
Medicine, Endocrinology, Obstetrics +13
ISLET-CELL ANTIBODIES IN DIABETES MELLITUS
R Lendrum · The Lancet · 1976 · 210 citations · Full text